Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 2, 1997, Pages 175-178

  Lindgren, S ^a   Braun, H B ^b   Michel, G ^b   Nemeth, A ^b   Nilsson, S ^b   Thome Kromer, B ^b   Eriksson, S ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Autoimmune hepatitis; Autoimmune liver disease; Chronic hepatitis C; LKM 1 autoantibodies

Indexed keywords

AUTOANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031033683     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709000189     Document Type: Article

References (27)

1. Rizetto M, Swana G, Doniach D. Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol 1973;15:331-4.
2. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991;88:1370-8.
3. Smith MGM, Williams R, Walker G, Rizetto M, Doniach D. Hepatic disorders associated with liver/kidney microsomal antibodies. Br Med J 1974;2:80-4.
4. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of 'autoimmune' hepatitis. Hepatology 1987;7:1333-9.
5. Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, et al. Anti-liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992;16:630-6.
6. Crivelli O, Lavarini C, Chiaberge E, Amoroso A, Farci P, Negro F, et al. Microsomal autoantibodies in chronic infection with the HBsAg associated delta agent. Clin Exp Immunol 1983;54:232-8.
7. Todros L, Touscoz G, D'Urso N, Durazzo M, Albano E, Poli G, et al. Hepatitis C-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). J Hepatol 1991;13:128-31.
8. Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, et al. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991;338:277-80.
9. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 1995;108:157-64.
10. Michel G, Ritter A, Gerken G, Meyer zum Büchenfelde KH, Decker R, Manns M. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992;339:267-9.
11. Olsson R, Lindberg J, Weiland O, Nilsson L. Chronic active hepatitis in Sweden. The etiologic spectrum, clinical presentation and laboratory profile. Scand J Gastroenterol 1988;23:463-70.
12. Lindgren S, Eriksson S, Deppner P, Wassmuth R. HLA DR, DQ and DP gene polymorphism in Swedish patients with primary biliary cirrhosis. J Hepatol 1995;23 Suppl 1:128.
13. Olsson R, Danielsson Å, Järnerot G, Lindström E, Lööf L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. An epidemiological study from five areas in Sweden. Gastroenterology 1991;100:1319-23.
14. Verbaan H, Andersson K, Eriksson S. Intravenous drug abuse - the major route of hepatitis C virus transmission among alcohol dependent individuals. Scand J Gastroenterol 1993;28:714-8.
15. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
16. Michel G, Braun H-B, Thome-Kromer B, Manns M, Röhrig K. Detection of anti-LKM-1 autoantibodies by microparticle capture enzyme immunoassay. Hepatology 1993;18 Suppl 2:216.
17. Manns M, Meyer zum Buchenfelde K-H, Slusarczyk J, Dienes HP. Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases. Clin Exp Immunol 1984;57:600-8.
18. Manns M, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. The major target of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450dbl. J Clin Invest 1989;83:1066-72.
19. Garson JA, Lenzi M, Ring C, Cassani F, Ballardini G, Briggs M, et al. Hepatitis C viraemia in adults with type 2 autöimmune hepatitis. J Med Virol 1991;34:223-6.
20. Alvarez F, Bernard O, Homberg JC, Kreibich G. Anti-liver-kidney microsome antibody recognizes a 50 000 molecular weight protein of the endoplasmic reticulum. J Exp Med 1985;161:1231-6.
21. Ma Y, Peakman M, Lobo-Yeo A, Wen L, Lenzi M, Oaken J, et al. Differences in immune recognition of cytochrome P450D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection. Clin Exp Immunol 1994;97:94-9.
22. Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli-Vergani G, Vergani D, et al. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 1995;37:406-12.
23. Gregersen PK. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease. Lab Invest 1989;61:5-19.
24. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility of autoimmune chronic active hepatitis: human leucocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991;13:701-6.
25. Burman P, Totterman TH, Öberg K, Karlsson FA. Thyroid autoimmunity in patients on long term therapy with leucocyte-derived Interferon. J Clin Endocrinol Metab 1986;63:1086-90.
26. Fattovich G, Betterle C, Brollo L, Pedini B, Guistina R, Realdi G, et al. Autoantibodies during alpha-interferon therapy for chronic hepatitis B. J Med Virol 1991;34:132-5.
27. McFarlane B, Bridger C, Tibbs CJ, Saleh MG, Fuzio A, Verucchi G, et al. Virus-induced autoimmunity in hepatitis C virus infections: a rare event. J Med Virol 1994;42:60-72.